Cargando…
Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone – a case report
BACKGROUND: Minoxidil solution has routinely been used for decades for the treatment of androgenic alopecia. Central serous chorioretinopathy (CSCR) is a rare side-effect noted following prolonged topical minoxidil therapy for androgenic alopecia. In this report, we describe a case of a 41-year-old...
Autores principales: | Venkatesh, Ramesh, Pereira, Arpitha, Jain, Kushagra, Yadav, Naresh Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275492/ https://www.ncbi.nlm.nih.gov/pubmed/32503484 http://dx.doi.org/10.1186/s12886-020-01499-6 |
Ejemplares similares
-
Oral Eplerenone Versus Observation in the Management of Acute Central Serous Chorioretinopathy: A Prospective, Randomized Comparative Study
por: Venkatesh, Ramesh, et al.
Publicado: (2020) -
Eplerenone Treatment in Chronic Central Serous Chorioretinopathy
por: Iqbal, Faisal, et al.
Publicado: (2021) -
Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone
por: Anderson, William J., et al.
Publicado: (2022) -
Real-world practice patterns of eplerenone use for central serous chorioretinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2023) -
Comment: Clinical profile of uveitis patients developing central serous chorioretinopathy - An experience at a tertiary eye care center in India
por: Aseem, Aditya, et al.
Publicado: (2019)